Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Gradalis, Sanofi, Monsanto, and More


Title: Construction of Bifunctional Short Hairpin RNA

Patent Number: 8,758,998

Filed: Feb. 1, 2012

Inventor: Donald Rao, Gradalis

Title: Host Cell Kinases as Targets for Antiviral Therapies against HCV Infection

Patent Number: 8,759,010

Filed: Sept. 8, 2009

Lead Inventor: Thomas Baumert, INSERM

Title: Short RNA Producing Gene Silencing in Cells

Patent Number: 8,759,102

Filed: Dec. 17, 2004

Lead Inventor: David Baulcombe, University of Cambridge (Plant Bioscience Limited)

Title: RNAi for the Control of Insects and Arachnids

Patent Number: 8,759,306

Filed: May 31, 2006

Inventor: Titus Jan Kaletta, Devgen (Syngenta)

Title: RNAi Probes Targeting Cancer-related Proteins

Patent Number: 8,759,308

Filed: July 28, 2010

Lead Inventor: Martin Gleave, University of British Columbia (OncoGenex)

Title: Use of siRNA Targeting SIPA1L1 for the Reduction of Adipogenesis

Patent Number: 8,759,311

Filed: Oct. 1, 2010

Lead Inventor: Diana Hall, Sanofi

Title: Methods and Compositions for Reducing Viral Genome Amounts in a Target Cell

Patent Number: 8,759,312

Filed: June 21, 2012

Lead Inventor: Peter Sarnow, Stanford University (Regulus Therapeutics)

Title: Treatment of Fibrosis using microRNA-19b

Patent Number: 8,759,313

Filed: Aug. 3, 2012

Lead Inventor: Laura Schrum, Charlotte-Mecklenburg Hospital

Title: Modulation of Exon Recognition in Pre-mRNA by Interfering RNA Structure

Patent Number: 8,759,507

Filed: Dec. 22, 2010

Inventor: Judith Van Deutekom, Leiden University Medical Center

Title: Methods for Genetic Control of Insect Infestation in Plants and Compositions Thereof

Patent Number: 8,759,611

Filed: Dec. 20, 2010

Lead Inventor: James Baum, Monsanto